Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Up 67.5% in August

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) saw a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 20,717 shares, a growth of 67.5% from the July 30th total of 12,368 shares. Based on an average trading volume of 4,199 shares, the short-interest ratio is presently 4.9 days.

Cardio Diagnostics Price Performance

Shares of CDIOW stock traded down $0.00 on Tuesday, hitting $0.02. The stock had a trading volume of 1,197 shares, compared to its average volume of 41,894. Cardio Diagnostics has a 1 year low of $0.01 and a 1 year high of $0.07. The company’s 50 day moving average price is $0.02 and its 200-day moving average price is $0.02.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.